182 related articles for article (PubMed ID: 25257165)
21. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
[TBL] [Abstract][Full Text] [Related]
22. Diffuse laminar endocervical glandular hyperplasia: a case report.
Dainty LA; Krivak TC; Webb JC; Zahn CM; Elkas JC; Chernofsky MR; Rose GS; Maxwell GL
Int J Gynecol Cancer; 2009 Aug; 19(6):1091-3. PubMed ID: 19820374
[TBL] [Abstract][Full Text] [Related]
23. A case of gastric-type adenocarcinoma of the uterine cervix associated with lobular endocervical glandular hyperplasia: radiologic-pathologic correlation.
Tsuboyama T; Yamamoto K; Nakai G; Yamada T; Fujiwara S; Terai Y; Ohmichi M; Narumi Y
Abdom Imaging; 2015 Mar; 40(3):459-65. PubMed ID: 25504516
[TBL] [Abstract][Full Text] [Related]
24. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
25. Uterine cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia: Radiologic-pathologic correlation.
Ohya A; Asaka S; Fujinaga Y; Kadoya M
J Obstet Gynaecol Res; 2018 Feb; 44(2):312-322. PubMed ID: 29144012
[TBL] [Abstract][Full Text] [Related]
26. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
Mikami Y; McCluggage WG
Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
[TBL] [Abstract][Full Text] [Related]
28. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum.
Nucci MR; Clement PB; Young RH
Am J Surg Pathol; 1999 Aug; 23(8):886-91. PubMed ID: 10435557
[TBL] [Abstract][Full Text] [Related]
29. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
[TBL] [Abstract][Full Text] [Related]
30. Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix.
Hayashi I; Tsuda H; Shimoda T; Maeshima A; Kasamatsu T; Yamada T; Tsunematsu R
Virchows Arch; 2003 Dec; 443(6):752-60. PubMed ID: 14556072
[TBL] [Abstract][Full Text] [Related]
31. Discriminant Analysis Using Gabor Filter Sets for Lobular Endocervical Glandular Hyperplasia: Numerical Interpretation of Nuclear Atypia by Gabor Filter Features.
Kimura F; Ohshima K; Shirai K; Kanai R; Sonohara M; Ishii K
Acta Cytol; 2023; 67(5):539-549. PubMed ID: 37497898
[TBL] [Abstract][Full Text] [Related]
32. Endocervical adenocarcinoma associated with lobular endocervical glandular hyperplasia showing rapid reaccumulation of hydrometra.
Takeuchi K; Tsujino T; Sugimoto M; Yoshida S; Kitazawa S
Int J Gynecol Cancer; 2008; 18(6):1285-8. PubMed ID: 18217972
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia.
Ota H; Harada O; Uehara T; Hayama M; Ishii K
Am J Clin Pathol; 2011 Feb; 135(2):253-61. PubMed ID: 21228366
[TBL] [Abstract][Full Text] [Related]
34. Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia.
Kimura F; Kobayashi T; Kanai R; Kobayashi Y; Yuhi O; Ota H; Yamaguchi M; Yokokawa Y; Uehara T; Ishii K
Diagn Cytopathol; 2019 Jun; 47(6):553-563. PubMed ID: 30761780
[TBL] [Abstract][Full Text] [Related]
35. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia.
Xu JY; Hashi A; Kondo T; Yuminamochi T; Nara M; Hashi K; Murata S; Katoh R; Hoshi K
Int J Gynecol Pathol; 2005 Jul; 24(3):296-302. PubMed ID: 15968208
[TBL] [Abstract][Full Text] [Related]
36. A case of endocervical minimal deviation adenocarcinoma with varicolored cytopathologic features on Pap smear.
Omori M; Kondo T; Nakazawa K; Shinohara S; Watanabe Y; Fukasawa H; Nakazawa T; Hashi A; Hirata S
Diagn Cytopathol; 2018 Aug; 46(8):702-706. PubMed ID: 29573230
[TBL] [Abstract][Full Text] [Related]
37. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
[TBL] [Abstract][Full Text] [Related]
38. The developing spectrum of gastric-type cervical glandular lesions.
Talia KL; McCluggage WG
Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
[TBL] [Abstract][Full Text] [Related]
39. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses.
Kondo T; Hashi A; Murata S; Nakazawa T; Yuminamochi T; Nara M; Hoshi K; Katoh R
Mod Pathol; 2005 Sep; 18(9):1199-210. PubMed ID: 15761489
[TBL] [Abstract][Full Text] [Related]
40. Tall-columnar glandular cells in SurePath™ liquid-based cytology Pap sample: Learning from mimics/pitfalls.
Gupta N; Jain V; Srinivasan R; Singh T
Cytopathology; 2024 Jul; 35(4):510-514. PubMed ID: 38712698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
